Center Hospitalier Universitaire d'Orléans
Orléans, 45067, France
Location status: Recruiting
NCT Number: NCT06746220
This is a prospective, comparative, double-blind, randomized, monocentric study.
The objective of this project is to evaluate the effects on health of probiotic supplementation (PS) with or without physical activity (PA). Participants who meet the study criteria will be randomized into 4 groups: probiotic and physical activity group (A+), probiotic and non-physical activity group (A-), placebo and physical activity group (T+), placebo and non-physical activity group (T-).
The probiotics used are Lactibiane® Reference provided by Pileje Laboratory. The study population are healthy women (university students) who do not practice sports. A total of 120 participants will participate.
At inclusion, each participant will undergo a medical examination, collect microbiota and salivary samples and perform different tests (questionnaires, assessments of strength and endurance). Then, a follow up phase will last 6 weeks. Each participant will receive a pillbox containing capsules (probiotic or placebo in a double-blind manner). Participants which randomized in the PA groups (A+ and A-) will perform 2 physical activity sessions per week for 6 weeks. At the end of this follow up phase, tests conducting during inclusion will be performed again.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Orléans, 45067, France
Location status: Recruiting
Rationale: Nowadays, the intestinal microbiota is recognized as a significant factor in the health of the host organism. It has an impact on the immune system, the hypothalamo-hypophyseal adrenal axis, the overall state of the individual such as body composition and muscle activity. The intestinal microbiota has also an impact on digestion and associated problems. However, its balance is fragile and can be easily disrupted by a diet rich in proteins or carbohydrates, medications, contraceptive use or lack of physical activity (PA).To restore this balance, subjects may modify their diet, take probiotic supplements (PS) or engage in physical activity. Currently, studies remain limited, particularly regarding effects of physical activity and/or probiotic have never been explored especially in women. The objective of this project is therefore to explore effects of PS and/or PA on the mental and physical health of the holobiont.
Method: Each participant will, during an initial visit, undergo a medical examination (ECG, anthropometric measurements) to ensure there are no contraindications to engaging in physical activity or taking probiotics. Then, we will conduct the first collections of intestinal microbiota and salivary cortisol, initial evaluations of anxiety, depression, and self-esteem (indicators of mental health with questionnaires), as well as assessments of strength and endurance (indicators of physical health), body composition, and nutritional parameters. Following this, participants will be assigned to experimental groups, and we will distribute pillboxes containing capsules (probiotic or placebo in a double-blind manner). Participants in the PA groups (A+ and A-) will perform two 45-minute physical activity sessions per week for 6 weeks, consisting of muscle strengthening and endurance exercises. Participants in the sedentary groups (T+ and T-) will be contacted by phone once a week to ensure proper protocol adherence. At the end of the 6 weeks, we will repeat the tests conducted during the initial visit.
Probiotics: The probiotics used are Lactibiane® Reference, composed of 4 probiotic strains (Bifidobacterium longum LA101, Lactobacillus helveticus LA102, Lactobacillus lactis LA103, Streptococcus thermophilus LA104) dosed at 10 billion per capsule provided by Pileje laboratory. Placebos are also provided by Pileje laboratory.
Statistics: Having no proven hypothesis on the effect of physical activity and/or probiotic supplementation on the population, we started with inclusion of 120 participants in total. This will allow to highlight a moderate effect size (0.25) for the primary endpoint, under the hypothesis of an alpha risk of 0.05, with a power of 80%. and representing 20% lost to follow-up.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Microbiota sample: one sample at inclusion and one sample at the end of the study
Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.
Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study
Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study
Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.
Physical activity: 2 sessions per week for 6 weeks. For each session, 45 minutes of physical activity consisting of muscle strengthening and endurance exercises.
Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal
Time frame: Measure of muscle mass will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Assessment of muscle mass with an impedance meter
Time frame: Measure of muscle mass will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Assessment of muscle mass with an impedance meter
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Test for endurance
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Test for upper limb (grip strength)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Test for lower limb (horizontal press test)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Test for upper limb (grip strength)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Test for lower limb (horizontal press test)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Test for endurance
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Eating behavior: food diary completed by participants for 3 consecutive days. Using specific software (nutrilog), analysis of quantitative energy intake (macronutrients and micronutrients)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Eating behavior: food diary completed by participants for 3 consecutive days. Using specific software (nutrilog), analysis of quantitative energy intake (macronutrients and micronutrients)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
effect of prebiotics: food diary completed by participants for 3 consecutive days. Using specific software (nutrilog), analysis of the content of foods rich in prebiotics (foods rich in fiber) in the diet.
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Microbiota: samples of stool with specific kit (MT0001G Gut Alive). Identify bacterial composition with 16S RNA sequencing
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Microbiota: samples of stool with specific kit (MT0001G Gut Alive). Identify bacterial composition with 16S RNA sequencing
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Salivary cortisol: samples of saliva with specific kit ("salitubes"). Free fraction of cortisol will be analysed by Enzyme-linked immunosorbent assays (ELISA)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Salivary cortisol: samples of saliva with specific kit ("salitubes"). Free fraction of cortisol will be analysed by Enzyme-linked immunosorbent assays (ELISA)
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Quality of life with MOS-SF36 questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Anxiety, depression with HAD questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Self-esteem with ISP-25 questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Effects of dietary supplement with EPCA questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Daily physical activity with IPAQ questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Quality of life with MOS-SF36 questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Anxiety, depression with HAD questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Self-esteem with ISP-25 questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Effects of dietary supplement with EPCA questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Daily physical activity with IPAQ questionnaire
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Fat mass: assessment of fat mass with an impedance meter
Time frame: Measure of secondary endpoints will be performed at inclusion and at the end of the study (an average of 2 months after inclusion)
Fat mass: assessment of fat mass with an impedance meter
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Régional d'Orléans
Other
Acronym: AP-Pro-Fem
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07095322
Behavior, Exercise
Glasgow, United Kingdom
View Trial DetailsNCT05777265
Behavior, Healthy Women
Izmir, Turkey (Türkiye)
View Trial DetailsNCT05777252
Behavior, Healthy Women
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07439458
Acute Exercise, Breast Cancer Cell Lines
Riga, Dzirciema Street 16, Latvia
View Trial Details